肺功能测试：口腔黏膜下纤维化患者的一个关键领域。
Pulmonary function test: A critical domain in oral submucous fibrosis patients.
作者信息
Mehrotra Vishal, Sambyal Sheenam, Mishra Gauri, Garg Kriti, Srivastava Rahul, Ishrat Saman
机构信息
Department of Oral Medicine and Radiology, Rama Dental College, Kanpur, Uttar Pradesh, India.
Department of Dentistry, Government Medical College, Jalaun, Uttar Pradesh, India.
出版信息
J Educ Health Promot. 2022 Jan 31;11:26. doi: 10.4103/jehp.jehp_587_21. eCollection 2022.
INTRODUCTION
The study aims to measure and compare pulmonary function tests (PFTs) in oral submucous fibrosis (OSMF) patients (smokers/nonsmokers) and normal individuals.
MATERIALS AND METHODS
The study population included 150 participants that comprised 50 nonsmoker OSMF patients, 50 OSMF patients who smoke as well, and 50 patients with no deleterious habits. Spirometer was used to assess PFT.
RESULTS
Results showed that a significant value was obtained for forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC, peak expiratory flow rate (PEFR), and maximum voluntary ventilation (MVV) and also for the predicted values of FEV, FEV1, FEV1/FVC, PEFR, and MVV in OSMF (smokers/nonsmokers) study groups.
CONCLUSION
Thus, the decrease in pulmonary function can be an alarming sign for restrictive type of pulmonary disease.
引言
本研究旨在测量和比较口腔黏膜下纤维化（OSMF）患者（吸烟者/非吸烟者）与正常个体的肺功能测试（PFTs）。
材料与方法
研究人群包括150名参与者，其中50名非吸烟的OSMF患者，50名吸烟的OSMF患者，以及50名无有害习惯的患者。使用肺活量计评估肺功能测试。
结果
结果显示，在OSMF（吸烟者/非吸烟者）研究组中，用力肺活量（FVC）、第1秒用力呼气容积（FEV1）、FEV1/FVC、呼气峰值流速（PEFR）和最大自主通气量（MVV）以及FEV、FEV1、FEV1/FVC、PEFR和MVV的预测值均获得了显著值。
结论
因此，肺功能下降可能是限制性肺病的一个警示信号。
Zotero 插件